These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 31170982)
1. Mapping analysis to estimate EQ-5D utility values using the COPD assessment test in Korea. Lim J; Choi SE; Bae E; Kang D; Lim EA; Shin GS Health Qual Life Outcomes; 2019 Jun; 17(1):97. PubMed ID: 31170982 [TBL] [Abstract][Full Text] [Related]
2. Mapping the COPD Assessment Test onto EQ-5D. Hoyle CK; Tabberer M; Brooks J Value Health; 2016 Jun; 19(4):469-77. PubMed ID: 27325339 [TBL] [Abstract][Full Text] [Related]
3. Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis. Chen G; Garcia-Gordillo MA; Collado-Mateo D; Del Pozo-Cruz B; Adsuar JC; Cordero-Ferrera JM; Abellán-Perpiñán JM; Sánchez-Martínez FI Patient; 2018 Dec; 11(6):665-675. PubMed ID: 29876865 [TBL] [Abstract][Full Text] [Related]
4. Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms. Doble B; Lorgelly P Qual Life Res; 2016 Apr; 25(4):891-911. PubMed ID: 26391884 [TBL] [Abstract][Full Text] [Related]
5. Mapping analysis to predict EQ-5D-5 L utility values based on the Oxford Hip Score (OHS) and Oxford Knee Score (OKS) questionnaires in the Spanish population suffering from lower limb osteoarthritis. Martín-Fernández J; Morey-Montalvo M; Tomás-García N; Martín-Ramos E; Muñoz-García JC; Polentinos-Castro E; Rodríguez-Martínez G; Arenaza JC; García-Pérez L; Magdalena-Armas L; Bilbao A Health Qual Life Outcomes; 2020 Jun; 18(1):184. PubMed ID: 32539838 [TBL] [Abstract][Full Text] [Related]
6. Mapping function from FACT-B to EQ-5D-5 L using multiple modelling approaches: data from breast cancer patients in China. Yang Q; Yu XX; Zhang W; Li H Health Qual Life Outcomes; 2019 Oct; 17(1):153. PubMed ID: 31615531 [TBL] [Abstract][Full Text] [Related]
7. Validity of EQ-5D utility index and minimal clinically important difference estimation among patients with chronic obstructive pulmonary disease. Bae E; Choi SE; Lee H; Shin G; Kang D BMC Pulm Med; 2020 Mar; 20(1):73. PubMed ID: 32293387 [TBL] [Abstract][Full Text] [Related]
8. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D. Hawton A; Green C; Telford C; Zajicek J; Wright D Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811 [TBL] [Abstract][Full Text] [Related]
9. Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data. Kim HL; Kim D; Jang EJ; Lee MY; Song HJ; Park SY; Cho SK; Sung YK; Choi CB; Won S; Bang SY; Cha HS; Choe JY; Chung WT; Hong SJ; Jun JB; Kim J; Kim SK; Kim TH; Kim TJ; Koh E; Lee H; Lee HS; Lee J; Lee SS; Lee SW; Park SH; Shim SC; Yoo DH; Yoon BY; Bae SC; Lee EK Rheumatol Int; 2016 Apr; 36(4):505-13. PubMed ID: 26849891 [TBL] [Abstract][Full Text] [Related]
10. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease. Moore A; Young CA; Hughes DA Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280 [TBL] [Abstract][Full Text] [Related]
11. Mapping the clinical chronic obstructive pulmonary disease questionnaire onto generic preference-based EQ-5D values. Boland MR; van Boven JF; Kocks JW; van der Molen T; Goossens LM; Chavannes NH; Rutten-van Mölken MP Value Health; 2015 Mar; 18(2):299-307. PubMed ID: 25773566 [TBL] [Abstract][Full Text] [Related]
12. Mapping algorithms for predicting EuroQol-5D-3L utilities from the assessment test of chronic obstructive pulmonary disease. Yu CH; Chang SM; Hsu CH; Tsai SH; Liao XM; Chen CW; Lin CH; Wang JD; Hsiue TR; Chen CZ Sci Rep; 2022 Dec; 12(1):20930. PubMed ID: 36463253 [TBL] [Abstract][Full Text] [Related]
14. Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D. Lamu AN; Olsen JA Qual Life Res; 2018 Nov; 27(11):2823-2839. PubMed ID: 30173314 [TBL] [Abstract][Full Text] [Related]
15. Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients. Kim SH; Jo MW; Kim HJ; Ahn JH Health Qual Life Outcomes; 2012 Dec; 10():151. PubMed ID: 23244763 [TBL] [Abstract][Full Text] [Related]
16. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis. Wong CKH; Cheung PWH; Samartzis D; Luk KD; Cheung KMC; Lam CLK; Cheung JPY PLoS One; 2017; 12(4):e0175847. PubMed ID: 28414745 [TBL] [Abstract][Full Text] [Related]
17. Predicting health-related quality of life (EQ-5D-5 L) and capability wellbeing (ICECAP-A) in the context of opiate dependence using routine clinical outcome measures: CORE-OM, LDQ and TOP. Peak J; Goranitis I; Day E; Copello A; Freemantle N; Frew E Health Qual Life Outcomes; 2018 May; 16(1):106. PubMed ID: 29843726 [TBL] [Abstract][Full Text] [Related]
18. Development of algorithms to estimate the EQ-5D-5L from the FACT-L in patients with lung cancer: a mapping study. Jiang L; Zhou H; Yang Q; Luo X; Huang D Qual Life Res; 2024 Mar; 33(3):805-816. PubMed ID: 38148367 [TBL] [Abstract][Full Text] [Related]
19. Predicting EQ-5D values using the SGRQ. Starkie HJ; Briggs AH; Chambers MG; Jones P Value Health; 2011; 14(2):354-60. PubMed ID: 21402304 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model. Franken MD; de Hond A; Degeling K; Punt CJA; Koopman M; Uyl-de Groot CA; Versteegh MM; van Oijen MGH Health Qual Life Outcomes; 2020 Jul; 18(1):240. PubMed ID: 32690011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]